774 related articles for article (PubMed ID: 9847632)
1. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group.
Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
Eur Respir J; 1998 Feb; 11(2):428-33. PubMed ID: 9551749
[TBL] [Abstract][Full Text] [Related]
3. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
[TBL] [Abstract][Full Text] [Related]
4. Long-term results after lung volume reduction surgery in patients with alpha1-antitrypsin deficiency.
Tutic M; Bloch KE; Lardinois D; Brack T; Russi EW; Weder W
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):408-13. PubMed ID: 15354100
[TBL] [Abstract][Full Text] [Related]
5. Aspects of treatment in alpha 1-antitrypsin deficiency: insights derived from a Swedish PiZZ series.
Eriksson S; Wu MC
Eur Respir J Suppl; 1990 Mar; 9():39s-43s. PubMed ID: 2340050
[TBL] [Abstract][Full Text] [Related]
6. [Substitution therapy in alpha 1-antitrypsin deficiency].
Konietzko N
Pneumologie; 2001 Jan; 55(1):1-3. PubMed ID: 11236351
[No Abstract] [Full Text] [Related]
7. A review of alpha-1 antitrypsin deficiency.
Ranes J; Stoller JK
Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1-antitrypsin replacement therapy: current status.
Abusriwil H; Stockley RA
Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
[TBL] [Abstract][Full Text] [Related]
10. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma.
van Veen IH; ten Brinke A; van der Linden AC; Rabe KF; Bel EH
Respir Med; 2006 Sep; 100(9):1534-9. PubMed ID: 16476537
[TBL] [Abstract][Full Text] [Related]
11. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
[TBL] [Abstract][Full Text] [Related]
12. Alpha one antitrypsin deficiency: from gene to treatment.
Wood AM; Stockley RA
Respiration; 2007; 74(5):481-92. PubMed ID: 17671403
[TBL] [Abstract][Full Text] [Related]
13. Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency.
Stoller JK; Gildea TR; Ries AL; Meli YM; Karafa MT;
Ann Thorac Surg; 2007 Jan; 83(1):241-51. PubMed ID: 17184672
[TBL] [Abstract][Full Text] [Related]
14. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.
Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC
Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021
[TBL] [Abstract][Full Text] [Related]
15. [Substitution of alpha 1-antitrypsin in patients with pulmonary emphysema and alpha 1-antitrypsin deficiency].
Schmidt EW; Rasche B; Ulmer WT
Verh Dtsch Ges Inn Med; 1988; 94():6-11. PubMed ID: 3264647
[No Abstract] [Full Text] [Related]
16. Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group.
Schluchter MD; Stoller JK; Barker AF; Buist AS; Crystal RG; Donohue JF; Fallat RJ; Turino GM; Vreim CE; Wu MC
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):796-801. PubMed ID: 10712324
[TBL] [Abstract][Full Text] [Related]
17. [Alpha 1-antitrypsin deficiency and emphysema. Replacement therapy?].
Johansen S; Gulsvik A
Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2142-5. PubMed ID: 2788939
[TBL] [Abstract][Full Text] [Related]
18. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.
Seersholm N; Wencker M; Banik N; Viskum K; Dirksen A; Kok-Jensen A; Konietzko N
Eur Respir J; 1997 Oct; 10(10):2260-3. PubMed ID: 9387950
[TBL] [Abstract][Full Text] [Related]
19. [A study of antielastase activity in the development of pulmonary emphysema in a family with alpha 1-antitrypsin deficiency].
Kishi F; Kakinoki A
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May; 27(5):565-70. PubMed ID: 2615095
[TBL] [Abstract][Full Text] [Related]
20. alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding.
Stoller JK; Aboussouan LS
Thorax; 2004 Aug; 59(8):708-12. PubMed ID: 15282394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
